Cambrex Corporation Pursues Strategic Alternatives for Rutherford Chemicals
Cambrex Corporation announced today that it has engaged Banc of America Securities LLC as financial advisor to assist the Company in investigating strategic alternatives for its Rutherford chemicals business segment. This engagement supports Cambrex' strategic objective of transitioning from a specialty and fine chemicals company to a leading life sciences company serving the human health industry.
"We are looking forward to working with the Banc of America team to help us explore and assess the various alternatives for the Rutherford Chemicals business," commented Sal Guccione, Executive Vice President Corporate Strategy and Development.
Most read news
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.